Keywords: نوآور; Biologic; Biosimilar; Biosimilarity; Characterization; Chronic inflammatory diseases; Clinical; Comparability; Development; Functional; Immunogenicity; Innovator; Manufacturing; Pharmacodynamics; Pharmacokinetics; Preclinical; Quality; Reference product;